Looking to expand your partner network with leading companies like 4D Pharma? Consider joining Inpart's global network for free.
News and Trends 8 Oct 2019
UK Company and Merck Team Up to Develop Vaccines Based on the Microbiome
Merck will pay the microbiome company 4D Pharma up to €316.5M to develop vaccines based on delivering live bacteria to the gut. The partners will develop vaccines against three undisclosed conditions. As well as an undisclosed upfront fee for each condition, 4D Pharma will be eligible to receive up to €316.5M ($347.5M) in developmental milestones. […]
